MED (STOCKS)
Medifast, Inc.
$10.590000
+0.530000 (+5.27%)
Prev close: $10.060000
Company Information
- Exchange
- XNYS
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- CEO
- Daniel R. Chard
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $116.40M
- Employees
- 504
- P/E (TTM)
- -6.25
- P/B (TTM)
- 0.56
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
4
Hold
4
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.65 | $-0.83 | -0.8218 | -99.23% |
|
Sep 2025 (Q3)
|
$-0.21 | $-0.39 | +0.1839 | +46.69% |
|
Jun 2025 (Q2)
|
$0.22 | $-0.22 | +0.4422 | +199.01% |
|
Mar 2025 (Q1)
|
$-0.11 | $-0.27 | +0.1627 | +59.66% |
Financial Statements
| Revenues | $385.79M |
| Benefits Costs and Expenses | $391.43M |
| Cost Of Revenue | $110.60M |
| Costs And Expenses | $391.43M |
| Gross Profit | $275.19M |
| Nonoperating Income/Loss | $8.57M |
| Operating Expenses | $289.40M |
| Selling, General, and Administrative Expenses | $289.40M |
| Research and Development | $4.30M |
| Operating Income/Loss | -$14.21M |
| Income/Loss From Continuing Operations After Tax | -$18.67M |
| Income/Loss From Continuing Operations Before Tax | -$5.64M |
| Income Tax Expense/Benefit | $13.03M |
| Income Tax Expense/Benefit, Current | $1.57M |
| Income Tax Expense/Benefit, Deferred | $11.46M |
| Net Income/Loss | -$18.67M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$18.67M |
| Net Income/Loss Available To Common Stockholders, Basic | -$18.67M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.70 |
| Diluted Earnings Per Share | -$1.70 |
| Basic Average Shares | 10,981,000 |
| Diluted Average Shares | 10,981,000 |
| Assets | $247.97M |
| Current Assets | $201.68M |
| Cash | $166.35M |
| Inventory | $20.23M |
| Other Current Assets | $15.10M |
| Noncurrent Assets | $46.29M |
| Fixed Assets | $31.23M |
| Other Non-current Assets | $15.06M |
| Liabilities | $49.05M |
| Current Liabilities | $42.96M |
| Noncurrent Liabilities | $6.09M |
| Equity | $198.92M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $198.92M |
| Liabilities And Equity | $247.97M |
| Net Cash Flow From Operating Activities | $6.86M |
| Net Cash Flow From Operating Activities, Continuing | $6.86M |
| Net Cash Flow From Investing Activities | -$7.93M |
| Net Cash Flow From Investing Activities, Continuing | -$7.93M |
| Net Cash Flow From Financing Activities | -$564.00K |
| Net Cash Flow From Financing Activities, Continuing | -$564.00K |
| Exchange Gains/Losses | $4.00K |
| Net Cash Flow | -$1.63M |
| Net Cash Flow, Continuing | -$1.63M |
| Comprehensive Income/Loss | -$18.62M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$18.62M |
| Other Comprehensive Income/Loss | -$18.62M |
| Other Comprehensive Income/Loss Attributable To Parent | $54.00K |